| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.0007 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |